|
1.
|
Fidler IJ: Rationale and methods for the
use of nude mice to study the biology and therapy of human cancer
metastasis. Cancer Metastasis Rev. 5:29–49. 1986.
|
|
2.
|
McLemore TL, Egglestone LC, Shoemaker RH,
Abbott BJ, Bohlman ME, Liu MC, Fine DL, Mayo JG and Boyd MR:
Comparison of intrapulmonary, percutaneous, intrathoracic, and
subcutaneous models for the propagation of human pulmonary and
non-pulmonary cancer cell lines in athymic nude mice. Cancer Res.
48:2880–2886. 1988.
|
|
3.
|
Yoshie O, Imai T and Nomiyama H: Novel
lymphocyte-specific CC chemokines and their receptors. J Leukoc
Biol. 62:634–644. 1997.
|
|
4.
|
Yoshie O, Imai T and Nomiyama H:
Chemokines in immunity. Adv Immunol. 78:57–110. 2001.
|
|
5.
|
Imai T, Hieshima K, Haskell C, Baba M,
Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ
and Yoshie O: Identification and molecular characterization of
fractalkine receptor CX3CR1, which mediates both leukocyte
migration and adhesion. Cell. 91:521–530. 1997.
|
|
6.
|
Umehara H, Bloom E, Okazaki T, Domae N and
Imai T: Fractalkine and vascular injury. Trends Immunol.
22:602–607. 2001.
|
|
7.
|
Doki Y, Murakami K, Yamaura T, Sugiyama S,
Misaki T and Saiki I: Mediastinal lymph node metastasis model by
orthotopic intrapulmonary implantation of Lewis lung carcinoma
cells in mice. Br J Cancer. 79:1121–1126. 1999.
|
|
8.
|
Nakamura ES, Koizumi K, Kobayashi M and
Saiki I: Inhibition of lymphangiogenesis-related properties of
murine lymphatic endothelial cells and lymph node metastasis of
lung cancer by the matrix metalloproteinase inhibitor MMI270.
Cancer Sci. 95:25–31. 2004.
|
|
9.
|
Koizumi K, Kozawa Y, Ohashi Y, Nakamura
ES, Aozuka Y, Sakurai H, Ichiki K, Doki Y, Misaki T and Saiki I:
CCL21 promotes the migration and adhesion of highly lymph node
meta-static human non-small cell lung cancer Lu-99 in vitro.
Oncol Rep. 17:1511–1516. 2007.
|
|
10.
|
Senda K, Koizumi K, Prangsaengtong O,
Minami T, Suzuki S, Takasaki I, Tabuchi Y, Sakurai H, Doki Y,
Misaki T and Saiki I: Inducible capillary formation in lymphatic
endothelial cells by blocking lipid phosphate phosphatase-3
activity. Lymphat Res Biol. 7:69–74. 2009.
|
|
11.
|
Cho S, Koizumi K, Takeno N, Kato S, Yamada
M, Hashimoto I, Sakurai H, Tsukada K and Saiki I: Antitumor effect
of combining CC chemokine 22 (CCL22) and an anti-CD25 antibody on
myeloma cells implanted subcutaneously into mice. Mol Med Rep.
2:773–777. 2009.
|
|
12.
|
Chada S, Ramesh R and Mhashilkar AM:
Cytokine- and chemokine-based gene therapy for cancer. Curr Opin
Mol Ther. 5:463–474. 2003.
|
|
13.
|
D'Elios MM, Del Prete G and Amedei A: New
frontiers in cell-based immunotherapy of cancer. Expert Opin Ther
Pat. 19:623–641. 2009.
|
|
14.
|
Bazan JF, Bacon KB, Hardiman G, Wang W,
Soo K, Rossi D, Greaves DR, Zrotnik A and Schall TJ: A new class of
membrane-bound chemokine with a CX3C motif. Nature. 385:640–644.
1997.
|
|
15.
|
Imaizumi T, Yoshida H and Satoh K:
Regulation of CX3CL1/fractalkine expression in endothelial cells. J
Atheroscler Thromb. 11:15–21. 2004.
|
|
16.
|
Kanazawa N, Nakamura T, Tashiro K,
Muramatsu M, Morita K, Yoneda K, Inaba K, Imamura S and Honjo T:
Fractalkine and macrophage-derived chemokine: T cell-attracting
chemokines expressed in T cell area dendritic cells. Eur J Immunol.
29:1925–1932. 1999.
|
|
17.
|
Hundhausen C, Misztela D, Berkhout TA,
Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R,
Matthews V, et al: The disintegrin-like metalloproteinase ADAM10 is
involved in constitutive cleavage of CX3CL1 (fractalkine) and
regulates CX3CL1-mediated cell-cell adhesion. Blood. 15:1186–1195.
2003.
|
|
18.
|
Garton KJ, Gough PJ, Blobel CP, Murphy G,
Greaves DR, Dempsey PJ and Raines EW: Tumor necrosis
factor-alpha-converting enzyme (ADAM17) mediates the cleavage and
shedding of fractalkine (CX3CL1). J Biol Chem. 12:37993–38001.
2001.
|
|
19.
|
Yamaura T, Doki Y, Murakami K and Saiki I:
Model for mediastinal lymph node metastasis produced by orthotopic
intra-pulmonary implantation of lung cancer cells in mice. Hum
Cell. 12:197–204. 1999.
|
|
20.
|
Yamaura T, Murakami K, Doki Y, Sugiyama S,
Misaki T, Yamada Y and Saiki I: Solitary lung tumors and their
spontaneous metastasis in athymic nude mice orthotopically
implanted with human non-small cell lung cancer. Neoplasia.
2:315–324. 2000.
|
|
21.
|
Ichiki K, Mitani N, Doki Y, Hara H, Misaki
T and Saiki I: Regulation of activator protein-1 activity in the
mediastinal lymph node metastasis of lung cancer. Clin Exp
Metastasis. 18:539–545. 2000.
|
|
22.
|
Vicari AP and Caux C: Chemokines in
cancer. Cytokine Growth Factor Rev. 13:143–154. 2002.
|
|
23.
|
Koizumi K, Hojo S, Akashi T, Yasumoto K
and Saiki I: Chemokine receptors in cancer metastasis and cancer
cell-derived chemokines in host immune response. Cancer Sci.
98:1652–1658. 2007.
|
|
24.
|
Ueno T, Toi M, Saji H, Muta M, Bando H,
Kuroi K, Koike M, Inadera H and Matsushima K: Significance of
macrophage chemoattractant protein-1 in macrophage recruitment,
angiogenesis, and survival in human breast cancer. Clin Cancer Res.
6:3282–3289. 2000.
|
|
25.
|
Luboshits G, Shina S, Kaplan O, Engelberg
S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben-Baruch
A: Elevated expression of the CC chemokine regulated on activation,
normal T cell expressed and secreted (RANTES) in advanced breast
carcinoma. Cancer Res. 59:4681–4687. 1999.
|
|
26.
|
Hojo S, Koizumi K, Tsuneyama K, Arita Y,
Cui Z, Shinohara K, Minami T, Hashimoto I, Nakayama T, Sakurai H,
et al: High-level expression of chemokine CXCL16 by tumor cells
correlates with a good prognosis and increased tumor-infiltrating
lymphocytes in colorectal cancer. Cancer Res. 15:4725–4731.
2007.
|
|
27.
|
Ohta M, Tanaka F, Yamaguchi H, Sadanaga N,
Inoue H and Mori M: The high expression of Fractalkine results in a
better prognosis for colorectal cancer patients. Int J Oncol.
26:41–47. 2005.
|
|
28.
|
Hyakudomi M, Matsubara T, Hyakudomi R,
Yamamoto T, Kinugasa S, Yamanoi A, Maruyama R and Tanaka T:
Increased expression of fractalkine is correlated with a better
prognosis and an increased number of both CD8+ T cells
and natural killer cells in gastric adenocarcinoma. Ann Surg Oncol.
15:1775–1782. 2008.
|
